Primary Site >> Colorectal Cancer

Gene >> DDX3X

Journal: Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):147-57.
Title: Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
Author: Mayer, R|Dillehay, L E|Shao, Y|Zhang, Y G|Song, S|Bartholomew, R M|Mackenson, D G|Williams, J R
PMID: 7721611
Journal: Anticancer Res. 1996 Nov-Dec;16(6B):3453-8.
Title: Effect of pre-irradiation on radiopharmaceutical localization in human colon tumor xenografts using mono- and bispecific monoclonal antibodies.
Author: Gridley, D S|Slater, J B|Mackensen, D G|Slater, J M
PMID: 9042206
Journal: Chin Med J (Engl). 2011 Nov;124(22):3778-85.
Title: Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Author: Chu, Zhong-Hua|Liu, Lu|Zheng, Chao-Xu|Lai, Wei|Li, Shou-Feng|Wu, Heng|Zeng, Yu-Jie|Zhao, Hai-Yan|Guan, Yu-Feng
PMID: 22340241
Journal: Oncotarget. 2015 Jul 30;6(21):18602-12.
Title: DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Author: Su, Chia-Yi|Lin, Tsung-Chieh|Lin, Yuan-Feng|Chen, Ming-Huang|Lee, Chien-Hsin|Wang, Hsuan-Yao|Lee, Yu-Chieh|Liu, Yu-Peng|Chen, Chi-Long|Hsiao, Michael
PMID: 26087195
Journal: Oncotarget. 2015 Sep 29;6(29):28312-26.
Title: Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
Author: Heerma van Voss, Marise R|Vesuna, Farhad|Trumpi, Kari|Brilliant, Justin|Berlinicke, Cynthia|de Leng, Wendy|Kranenburg, Onno|Offerhaus, G Johan|Burger, Horst|van der Wall, Elsken|van Diest, Paul J|Raman, Venu
PMID: 26311743
Journal: Sci Rep. 2016 Feb 19;6:21483.
Title: DDX3 promotes tumor invasion in colorectal cancer via the CK1epsilon/Dvl2 axis.
Author: He, Tsung-Ying|Wu, De-Wei|Lin, Po-Lin|Wang, Lee|Huang, Chi-Chou|Chou, Ming-Chih|Lee, Huei
PMID: 26892600
Journal: Oncotarget. 2016 Apr 19;7(16):22687-99.
Title: DDX3 enhances oncogenic KRASinduced tumor invasion in colorectal cancer via the betacatenin/ZEB1 axis.
Author: Wu, De-Wei|Lin, Po-Lin|Cheng, Ya-Wen|Huang, Chi-Chou|Wang, Lee|Lee, Huei
PMID: 27007150
Journal: Am J Cancer Res. 2016 Jan 15;6(2):387-402. eCollection 2016.
Title: Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.
Author: Zhao, Luqing|Mao, Yitao|Zhou, Jianhua|Zhao, Yuelong|Cao, Ya|Chen, Xiang
PMID: 27186411
Journal: Cell Mol Life Sci. 2017 Jul;74(13):2395-2411.
Title: Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.
Author: He, Liangmei|Chen, Yayun|Wu, Yuanbing|Xu, Ying|Zhang, Zixiang|Liu, Zhiping
PMID: 28224203
Journal: Theranostics. 2017 Feb 27;7(5):1114-1132.
Title: The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer.
Author: Wu, De-Wei|Lin, Po-Lin|Wang, Lee|Huang, Chi-Chou|Lee, Huei
PMID: 28435452
Journal: Onco Targets Ther. 2017 Jul 17;10:3501-3513.
Title: Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.
Author: Heerma van Voss, Marise R|Vesuna, Farhad|Bol, Guus M|Meeldijk, Jan|Raman, Ana|Offerhaus, G Johan|Buerger, Horst|Patel, Arvind H|van der Wall, Elsken|van Diest, Paul J|Raman, Venu
PMID: 28761359
Journal: Oncotarget. 2017 Dec 15;8(70):115280-115289.
Title: Role of DDX3 in the pathogenesis of inflammatory bowel disease.
Author: Tantravedi, Saritha|Vesuna, Farhad|Winnard, Paul T Jr|Van Voss, Marise R Heerma|Van Diest, Paul J|Raman, Venu
PMID: 29383159